These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22777068)

  • 1. [New kinase inhibitors].
    Rubbert-Roth A
    Z Rheumatol; 2012 Aug; 71(6):479-84. PubMed ID: 22777068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intracellular signaling transduction pathways. Potential targets in the treatment of rheumatic diseases].
    Frommer KW; Geyer M; Firestein GS
    Z Rheumatol; 2012 Aug; 71(6):460-7. PubMed ID: 22875571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinase inhibitors: the next generation of therapies in the treatment of rheumatoid arthritis.
    MacFarlane LA; Todd DJ
    Int J Rheum Dis; 2014 May; 17(4):359-68. PubMed ID: 24460872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting kinases: a new approach to treating inflammatory rheumatic diseases.
    Simmons DL
    Curr Opin Pharmacol; 2013 Jun; 13(3):426-34. PubMed ID: 23523202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinase inhibitors: a new class of antirheumatic drugs.
    Kyttaris VC
    Drug Des Devel Ther; 2012; 6():245-50. PubMed ID: 23055694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Janus kinase inhibitors for rheumatoid arthritis.
    Yamaoka K
    Curr Opin Chem Biol; 2016 Jun; 32():29-33. PubMed ID: 26994322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts in the management of rheumatoid arthritis.
    Tanaka Y
    Korean J Intern Med; 2016 Mar; 31(2):210-8. PubMed ID: 26932398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical.
    Tanaka Y; Yamaoka K
    Mod Rheumatol; 2013 May; 23(3):415-24. PubMed ID: 23212593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in clinical trials for rheumatic diseases].
    Tanaka Y
    Nihon Rinsho; 2009 Mar; 67(3):619-25. PubMed ID: 19280942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [JAK inhibitor].
    Yamaoka K; Tanaka Y
    Nihon Rinsho; 2013 Jul; 71(7):1243-7. PubMed ID: 23961674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new therapeutical option for chronic inflammation in rheumatology: janus kinases inhibitors (JAK)].
    Varisco PA; So A
    Rev Med Suisse; 2014 Jan; 10(414):187-91. PubMed ID: 24624736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conventional basis therapy of rheumatoid arthritis. Effects within and outside cells].
    Keyßer G
    Z Rheumatol; 2012 Aug; 71(6):468-72. PubMed ID: 22802023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis.
    Nakayamada S; Kubo S; Iwata S; Tanaka Y
    BioDrugs; 2016 Oct; 30(5):407-419. PubMed ID: 27577235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the future of targeted therapy in rheumatology: biologics or small molecules?
    Mócsai A; Kovács L; Gergely P
    BMC Med; 2014 Mar; 12():43. PubMed ID: 24620738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in understanding the safety and efficacy of Janus kinase inhibitors for treatment of rheumatoid arthritis.
    Iwata S; Tanaka Y
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1047-57. PubMed ID: 27253519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic rheumatic diseases: From biological agents to small molecules.
    Sarzi-Puttini P; Ceribelli A; Marotto D; Batticciotto A; Atzeni F
    Autoimmun Rev; 2019 Jun; 18(6):583-592. PubMed ID: 30959214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK inhibitors for the treatment of rheumatoid arthritis.
    Morinobu A
    Immunol Med; 2020 Dec; 43(4):148-155. PubMed ID: 32501149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Janus kinase inhibitors].
    Ostermeier E; Roll P; Tony HP
    Z Rheumatol; 2012 Aug; 71(6):473-8. PubMed ID: 22802024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.
    Machado MAÁ; Moura CS; Guerra SF; Curtis JR; Abrahamowicz M; Bernatsky S
    Arthritis Res Ther; 2018 Mar; 20(1):60. PubMed ID: 29566769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bruton's tyrosine kinase as a drug discovery target.
    Pan Z
    Drug News Perspect; 2008 Sep; 21(7):357-62. PubMed ID: 19259548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.